ResearcherUniversity of MissouriActive in the last 2 years
Nagabhishek Sirpu Natesh
Matched on ORCID iD 0000-0003-3826-1591; OpenAlex author ID A5114044414. Sources: OpenAlex.
Their work
- Papers
- 5
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 13
2021: 2 papers · 2022: none · 2023: 1 paper · 2024: none · 2025: 2 papers
Papers 5
- Niclosamide-Loaded Polyanhydride Nanoparticles to Combat Gemcitabine Resistance in Pancreatic Cancer. Co-author DOI 10.1007/s40883-025-00394-0↗
- Niclosamide nanoparticles enhance pancreatic cancer sensitivity to gemcitabine via HIF-1α inhibition. Co-author DOI 10.1016/j.isci.2025.114088↗
- Histidine Enhances the Anticancer Effect of Gemcitabine against Pancreatic Cancer via Disruption of Amino Acid Homeostasis and Oxidant-Antioxidant Balance. Co-author DOI 10.3390/cancers15092593↗
- Nuclear factor kappa-B contributes to cigarette smoke tolerance in pancreatic ductal adenocarcinoma through cysteine metabolism. Co-author DOI 10.1016/j.biopha.2021.112312↗
- Emerging Role of miR-345 and Its Effective Delivery as a Potential Therapeutic Candidate in Pancreatic Cancer and Other Cancers. Co-author DOI 10.3390/pharmaceutics13121987↗
Closest collaborators
The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Surinder K. Batra · 5 shared papers, 2021–2025 · strength 0.93
- Paper Niclosamide nanoparticles enhance pancreatic cancer sensitivity to gemcitabine via HIF-1α inhibition. DOI 10.1016/j.isci.2025.114088↗
- Paper Niclosamide-Loaded Polyanhydride Nanoparticles to Combat Gemcitabine Resistance in Pancreatic Cancer. DOI 10.1007/s40883-025-00394-0↗
- Paper Histidine Enhances the Anticancer Effect of Gemcitabine against Pancreatic Cancer via Disruption of Amino Acid Homeosta… DOI 10.3390/cancers15092593↗
- Satyanarayana Rachagani · 5 shared papers, 2021–2025 · strength 0.93
- Paper Niclosamide nanoparticles enhance pancreatic cancer sensitivity to gemcitabine via HIF-1α inhibition. DOI 10.1016/j.isci.2025.114088↗
- Paper Niclosamide-Loaded Polyanhydride Nanoparticles to Combat Gemcitabine Resistance in Pancreatic Cancer. DOI 10.1007/s40883-025-00394-0↗
- Paper Histidine Enhances the Anticancer Effect of Gemcitabine against Pancreatic Cancer via Disruption of Amino Acid Homeosta… DOI 10.3390/cancers15092593↗
- Brianna M. White · 3 shared papers, 2021–2025 · strength 0.63
- Paper Niclosamide nanoparticles enhance pancreatic cancer sensitivity to gemcitabine via HIF-1α inhibition. DOI 10.1016/j.isci.2025.114088↗
- Paper Niclosamide-Loaded Polyanhydride Nanoparticles to Combat Gemcitabine Resistance in Pancreatic Cancer. DOI 10.1007/s40883-025-00394-0↗
- Paper Emerging Role of miR-345 and Its Effective Delivery as a Potential Therapeutic Candidate in Pancreatic Cancer and Other… DOI 10.3390/pharmaceutics13121987↗
- Venugopal Gunda · 3 shared papers, 2021–2025 · strength 0.62
- Paper Niclosamide nanoparticles enhance pancreatic cancer sensitivity to gemcitabine via HIF-1α inhibition. DOI 10.1016/j.isci.2025.114088↗
- Paper Niclosamide-Loaded Polyanhydride Nanoparticles to Combat Gemcitabine Resistance in Pancreatic Cancer. DOI 10.1007/s40883-025-00394-0↗
- Paper Nuclear factor kappa-B contributes to cigarette smoke tolerance in pancreatic ductal adenocarcinoma through cysteine me… DOI 10.1016/j.biopha.2021.112312↗
- Balaji Narasimhan · 2 shared papers, 2025 · strength 0.49
- Susheel Kumar Nethi · 2 shared papers, 2025 · strength 0.49
- Robert Powers · 1 shared paper, 2023 · strength 0.17
- Viswanathan Saraswathi · 1 shared paper, 2023 · strength 0.17
- Narendra Kumar · 1 shared paper, 2023 · strength 0.17
- Jyoti Kaushal · 1 shared paper, 2023 · strength 0.17
- Metin Uz · 1 shared paper, 2021 · strength 0.14
- Sakthivel Muniyan · 1 shared paper, 2021 · strength 0.13
- Daryl J. Murry · 1 shared paper, 2021 · strength 0.13
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.